VAIA, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 300
AS - Asia 271
NA - Nord America 74
SA - Sud America 59
AF - Africa 6
Totale 710
Nazione #
RU - Federazione Russa 240
SG - Singapore 104
CN - Cina 72
US - Stati Uniti d'America 66
BR - Brasile 46
IT - Italia 38
VN - Vietnam 29
HK - Hong Kong 17
KR - Corea 14
JP - Giappone 12
IN - India 9
AR - Argentina 6
AT - Austria 6
EC - Ecuador 5
MX - Messico 5
ZA - Sudafrica 5
FR - Francia 4
ID - Indonesia 4
NL - Olanda 4
PK - Pakistan 4
DE - Germania 3
CA - Canada 2
FI - Finlandia 2
GB - Regno Unito 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CO - Colombia 1
EG - Egitto 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
PL - Polonia 1
VE - Venezuela 1
Totale 710
Città #
Moscow 87
Singapore 50
Hefei 25
Hong Kong 17
Naples 16
Dallas 15
Seoul 14
Ashburn 13
Ho Chi Minh City 13
Beijing 8
Santa Clara 8
Bengaluru 7
São Paulo 7
Hanoi 6
Sialkot 4
Viterbo 4
Amsterdam 3
Da Nang 3
Mexico City 3
Milan 3
Rome 3
Boardman 2
Brasília 2
Cape Town 2
Guayaquil 2
Los Angeles 2
New York 2
Nuremberg 2
Porto Alegre 2
Rio Paranaíba 2
San Cesareo 2
San Luis 2
Sant'Antonio Abate 2
Tashkent 2
Ubatuba 2
Vienna 2
Al Ain City 1
Alexandria 1
Almaty 1
Anagé 1
Anápolis 1
Aversa 1
Bertioga 1
Bethlehem 1
Bishkek 1
Bom Retiro do Sul 1
Braúnas 1
Bắc Ninh 1
Cabo Frio 1
Campos do Jordão 1
Canela 1
Cañuelas 1
Chennai 1
Ciudad Guayana 1
Curiúva 1
Fairburn 1
Frankfurt am Main 1
Fushun 1
Gainesville 1
Guadalajara 1
Guangzhou 1
Haiphong 1
Helsinki 1
Hải Dương 1
Itajaí 1
Jaú 1
Jersey City 1
Jinan 1
Johannesburg 1
Krugersdorp 1
Lanús 1
Lappeenranta 1
Las Vegas 1
Liverpool 1
Longchamps 1
Lấp Vò 1
Madre de Deus 1
Manassas 1
Manaus 1
Manta 1
Menteng 1
Mogi das Cruzes 1
Montreal 1
Ninh Bình 1
Niterói 1
Noida 1
Pará de Minas 1
Pelotas 1
Ponta Grossa 1
Ponte Nova 1
Porto Seguro 1
Presidente Derqui 1
Quirinópolis 1
Quito 1
Roubaix 1
Samarinda 1
San Francisco 1
Santa Luzia 1
Santana do Livramento 1
Scandicci 1
Totale 403
Nome #
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 67
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 65
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 64
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 63
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 55
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 52
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 49
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 47
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 45
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 42
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 40
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 37
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 36
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 29
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 20
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 18
Totale 729
Categoria #
all - tutte 1.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202411 0 0 0 0 0 0 0 0 2 1 4 4
2024/2025112 0 0 0 0 8 3 19 15 17 13 15 22
2025/2026606 52 98 83 57 147 169 0 0 0 0 0 0
Totale 729